Drug Shortage Report for TEVA-ESOMEPRAZOLE
| Report ID | 231430 |
| Drug Identification Number | 02423863 |
| Brand name | TEVA-ESOMEPRAZOLE |
| Common or Proper name | ESOMEPRAZOLE 40MG OG TABLET |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | ESOMEPRAZOLE |
| Strength(s) | 40MG |
| Dosage form(s) | TABLET (DELAYED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 30 UD |
| ATC code | A02BC |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-06-26 |
| Estimated end date | 2024-10-31 |
| Actual end date | 2024-10-31 |
| Shortage status | Resolved |
| Updated date | 2024-11-01 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2024-11-01 | French | Compare |
| v9 | 2024-11-01 | English | Compare |
| v8 | 2024-10-11 | French | Compare |
| v7 | 2024-10-11 | English | Compare |
| v6 | 2024-09-05 | French | Compare |
| v5 | 2024-09-05 | English | Compare |
| v4 | 2024-07-11 | French | Compare |
| v3 | 2024-07-11 | English | Compare |
| v2 | 2024-06-27 | French | Compare |
| v1 | 2024-06-27 | English | Compare |
Showing 1 to 10 of 10